New Delhi: The World Health Organization has granted Bharat Biotech's Covaxin an Emergency Use Listing, said sources on Wednesday evening, which means the COVID-19 vaccine will now be recognised by other countries. Moreover, Indians who have received the 'Made-in-India' shot need not self-quarantine or face restrictions when travelling abroad.
The development comes on a day the country reported 11,903 fresh COVID-19 cases in the last 24 hours, which was 14% higher than yesterday. The country also witnessed 311 Covid-related deaths during the period.
With 14,159 recoveries reported in the last 24 hours, the cumulative recoveries reached 3,36,97,740. Consequently, the recovery rate is currently at 98.22 per cent, the highest since March 2020.
Last month, India's total COVID-19 vaccine doses administered crossed the 100-crore mark.
Here are the Highlights on Coronavirus Cases In India:
Nov 03, 2021 17:33 (IST)
WHO Clears Bharat Biotech's Covaxin For Emergency Use: Sources
The World Health Organization has granted Bharat Biotech's Covaxin an Emergency Use Listing, said sources on Wednesday evening, which means the COVID-19 vaccine will be recognised by other countries and Indians who have received the shot need not self-quarantine or face restrictions when travelling abroad.
Nov 03, 2021 14:23 (IST)
COVID-19 Vaccination Drive Should Be Taken Door-To-Door: PM Modi
Prime Minister Narendra Modi on Wednesday asserted that the COVID-19 vaccination drive needed to be taken door-to-door and asked officials of districts having low inoculation to adopt innovative ways to boost the campaign. PM Modi made the remarks at a meeting, held via video conferencing, with district magistrates of over 40 districts having low vaccination coverage. Pointing out that he recently met Pope Francis at the Vatican City, the prime minister said special emphasis was needed on taking message of religious leaders spreading awareness and encouraging the vaccination drive to the people.
